본문 바로가기

logo

HOME
CONTACT

PR

Accuracy with expediency

Media Coverage

HOME
PR
Media Coverage

2023 05.10		Pinotbio seeks preliminary review of listing on Kosdaq
2023 01.26		Bridge Biotherapeutics, Pinotbio join hands to develop cancer therapeutics using ADCs
2023 01.04		Korean biopharma firms actively develop ADC drugs through ‘open innovation’
2022 12.20		Six start-ups win Innovation Start-up Korea Awards
2022 10.21		Celltrion bulks out ADC ambition with Pinotbio tech deal
2022 08.23		ADCs Are The Future Of Precision Chemotherapeutics
2022 07.13		Aptamer Group and PinotBio Extend Collaboration Agreement
2022 06.19		Birmingham organization advancing cancer treatment research
2021 06.02		Aptamer Group and PinotBio collaborate to develop new therapeutic drug conjugates

1